Granted Patent
B2
US 7,956,062 · App. 12/554,249 · Granted Jun 7, 2011
Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
Assignee:
Duke University
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A reactive oxygen generating enzyme inhibitor with NO donor bioactivity, e.g., nitrated allopurinol, is useful to treat heart failure, stable angina, ischemic disorder, ischemic reperfusion injury, atherosclerosis, sickle cell disease, diabetes, Alzheimer's disease, Parkinson's disease, ALS and asthma and to obtain proper contraction of heart, skeletal and smooth muscle.
Claims (1)
1. A method for treating leg pain in a patient with leg pain associated with diabetes comprising administering to the patient bis(3-nitrooxypropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one in an amount to mediate a decrease in leg pain or an increase in walking distance compared to the walking distance before treatment.
Assignments (1)
CONFIRMATORY LICENSE
Recorded Oct 30, 2017
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044322/0891 →
Continuity (3)